Search - tctmd.com

Displaying 121 - 140 of 225

Sort: Relevancy | Date

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Presenter: Gary M. Ansel, J. A. Mustapha, Ron Waksman

October 12, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Presenter: Dean J. Kereiakes, Ron Waksman, Davide Capodanno, Michael Haude

October 12, 2015

Presentation TCT 2015

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

What Are Bioresorbable Scaffolds (BRS), and Why Do We Need Them?

Presenter: Thomas H. Maloney, Ron Waksman

October 11, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

Registry Study: Embolic Protection Does Not Appear to Improve SVG PCI Outcomes

Todd Neale

March 27, 2015

Presentation ISET 2015

Is There Hope for Renal Denervation?

Presenter: Ron Waksman

February 01, 2015

Presentation ICI 2014

Infrared Technology to Detect Vulnerable Plaque The LRP Studies

Presenter: Ron Waksman

December 14, 2014

News Daily News

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Salynn Boyles

December 11, 2014

News Daily News

一项实际案例研究表明仅治疗STEMI中的罪犯血管是有益的

Yael L. Maxwell

November 06, 2014

News Daily News

Un Estudio del Mundo Real Revela los Beneficios de Tratar Solo el Vaso Causante en Casos de STEMI

Yael L. Maxwell

November 06, 2014

News Daily News

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Yael L. Maxwell

November 06, 2014

News Daily News

在患贫血的TAVR患者中输血与死亡率增加有联系

L.A. McKeown

November 02, 2014

News Daily News

Transfusions Linked to Increased Mortality in Anemic TAVR Patients

L.A. McKeown

November 02, 2014

News Daily News

Las Transfusiones se asocian a una Mayor Mortalidad en Pacientes Anémicos TAVR

L.A. McKeown

November 02, 2014

News Daily News

先前——但不是新发作——房颤可预测TAVR后的长期结果更差

October 17, 2014

Advertisement

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

What Are Bioresorbable Scaffolds (BRS), and Why Do We Need Them?

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

Registry Study: Embolic Protection Does Not Appear to Improve SVG PCI Outcomes

Is There Hope for Renal Denervation?

Infrared Technology to Detect Vulnerable Plaque The LRP Studies

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

一项实际案例研究表明仅治疗STEMI中的罪犯血管是有益的

Un Estudio del Mundo Real Revela los Beneficios de Tratar Solo el Vaso Causante en Casos de STEMI

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

在患贫血的TAVR患者中输血与死亡率增加有联系

Transfusions Linked to Increased Mortality in Anemic TAVR Patients

Las Transfusiones se asocian a una Mayor Mortalidad en Pacientes Anémicos TAVR

先前——但不是新发作——房颤可预测TAVR后的长期结果更差

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content